Regeneron Pharmaceuticals
REGN
#251
Rank
ยฃ70.79 B
Marketcap
ยฃ684.37
Share price
1.73%
Change (1 day)
37.37%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): ยฃ30.33

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ31.18. In 2022 the company made an earnings per share (EPS) of ยฃ30.14 a decrease over its 2021 EPS that were of ยฃ56.87.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ30.330.62%
2022ยฃ30.14-47%
2021ยฃ56.87133.36%
2020ยฃ24.3769.13%
2019ยฃ14.41-14.44%
2018ยฃ16.84100.71%
2017ยฃ8.3931.78%
2016ยฃ6.3738.96%
2015ยฃ4.5872.55%
2014ยฃ2.66-17.55%
2013ยฃ3.22-44.98%
2012ยฃ5.85-422.54%
2011-ยฃ1.8292.13%
2010-ยฃ0.9449.41%
2009-ยฃ0.63-15.84%
2008-ยฃ0.75-36.88%
2007-ยฃ1.19-9.6%
2006-ยฃ1.324.12%
2005-ยฃ1.26-323.68%
2004ยฃ0.57-135.51%
2003-ยฃ1.59-24.38%
2002-ยฃ2.1156.35%
2001-ยฃ1.35187.3%
2000-ยฃ0.47-16%
1999-ยฃ0.56177.78%
1998-ยฃ0.20-35.71%
1997-ยฃ0.31-68.42%
1996-ยฃ0.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ4.97-84.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.91-87.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ12.07-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.42-95.46%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.76-94.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.74-52.73%๐Ÿ‡บ๐Ÿ‡ธ USA